Health

140 readers
1 users here now

A community about human health and fitness. All health topics are welcomed here, from mental health to dieting to reproductive health.


Rules

founded 2 years ago
MODERATORS
1
 
 

TL;DR: No, it's a confounding variable, because more affluent people are more likely to be screened, despite the Post's wanna-be eugenics-justifying title.

"A new, large study out of Finland suggests that people with good jobs have a greater genetic risk for cancer, especially breast and prostate cancers," but Dr. Jiyoung Ahn "believes screening behavior is key to this research," saying, "It is well-established that if you have higher socioeconomic status, you are more likely to get screened."

2
 
 

cross-posted from: https://midwest.social/post/14378121

Adolescents who experienced housing insecurity beginning in infancy reported worse overall health outcomes, including anxiety and depressive symptoms, according to study results published in Pediatrics.

It is known that housing insecurity adversely affects child growth and abstract development, but less is known about the cumulative long-term effects, they wrote in the study.

3
 
 

cross-posted from: https://midwest.social/post/14378121

Adolescents who experienced housing insecurity beginning in infancy reported worse overall health outcomes, including anxiety and depressive symptoms, according to study results published in Pediatrics.

It is known that housing insecurity adversely affects child growth and abstract development, but less is known about the cumulative long-term effects, they wrote in the study.

4
 
 

HIV-related programs in Maryland are facing significant funding cuts after a surplus fund operated by the Maryland Department of Health ran out of money last fiscal year. The Baltimore City Health Department's letter announced a 76% reduction in state funding for HIV programs, dropping expected funds from $22 million to $5.3 million. Kim Holmes, a volunteer with Project PLASE, said, "It's sad. It's really sad. You got something that's working. Why, if it's working, why try to break it?"

(Use readability to see full text)

5
 
 

cross-posted from: https://midwest.social/post/14342600

A study published in JAMA Network Open by Included Health and Harvard Medical School found that patients in high deductible health plans are less likely to seek virtual behavioral healthcare when costs are reintroduced. The study analyzed 15,000 patients and revealed that those required to pay out-of-pocket attended 1.5 fewer telemental health visits per month, with 11.7% stopping visits altogether.

6
 
 

Eight weeks of acupuncture was found to reduce the dose of methadone needed to control opioid cravings, which could make patients likelier to stick with their treatment.

7
 
 

cross-posted from: https://midwest.social/post/14305293

Large nonprofit health systems like Geisinger, Ascension, and Henry Ford are forming joint ventures with investor-owned psychiatric hospital operators such as Acadia and Universal Health Services. While these hospitals often carry the names of the nonprofits, for-profit companies with questionable track records manage day-to-day operations.

8
 
 

cross-posted from: https://midwest.social/post/14297883

Between the ages of 8 and 12, MRI scans of children with ADHD show significantly lower cerebral blood flow in regions of the brain known to be related to attention, motor skills, executive function and impulsivity.

(Conclusively demonstrating that it's not just "in someone's head")

9
 
 

Millions of Americans likely to develop and die from heart disease live in cardiology deserts — areas of the country without a single heart specialist to care for them.

New research published Monday in the Journal of the American College of Cardiology finds that nearly half of all counties in the U.S. lack a practicing cardiologist.

Most of those counties are rural, with residents who tend to be sicker in general with complex medical problems.

“The counties that do not have cardiologists probably need this type of specialty care even more,” said the study’s senior author, Dr. Haider Warraich, a cardiologist at Brigham and Women’s Hospital in Boston.

10
 
 

cross-posted from: https://midwest.social/post/14265061

Pregnant women enrolled in a federal aid program have better outcomes than those who are struggling to put food on the table, new research shows.

The new study, from a team at Ohio State University, found that women enrolled in WIC had a lower risk of poor pregnancy outcomes. Those outcomes included gestational diabetes, blood transfusion, preterm birth and stays in intensive care for mom and baby alike.

The study dovetails with concerns about Congressional proposals to slash WIC funding for the first time.

11
 
 

cross-posted from: https://midwest.social/post/14149201

Medicare is initiating an eight-year pilot project, GUIDE, to provide direct support to caregivers of dementia patients, aiming to alleviate the emotional and financial burdens they face. The program will provide care coordinators to assist families with managing symptoms, coordinating medical visits, and arranging short-term care, with the goal of keeping patients healthier and at home longer. This initiative is expected to reduce hospitalization rates and save Medicare money, although its long-term cost-effectiveness remains uncertain.

12
 
 

The new market report titled ‘Plasma Fractionation Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the Plasma Fractionation Market.

The plasma fractionation market size is estimated to grow from USD 4.80 billion in 2024 to USD 12.70 billion by 2035, representing a CAGR of 10% during the forecast period 2023-2035. The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The Plasma Fractionation Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet.

Plasma Fractionation Market Characterization: Market Scope and Market Size: The Plasma Fractionation Market is broadly segmented on the basis of Focus on Distribution by Type of Company, Scale of Operation, Type of Plasma-derived Therapeutic Products Manufactured, Therapeutic Areas of Plasma-derived Products and Key Geographical Regions. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the Plasma Fractionation Market in terms of market size & volume and significant information pertaining to product bifurcation and application overview.

Key Market Contenders: This particular section of the report covers all the necessary details of the renowned market players operating in the Plasma Fractionation Market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market.

Key players Baxter, Bio Products Laboratory (BPL), Biotest, CSL (CSL Behring), Grifols, Kedrion, LFB Plasma, Octapharma, Shanghai RAAS Blood Products and Takeda Pharmaceutical company.

The section of this report focusing on the competitive terrain of the Plasma Fractionation Market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period.

Main chapters covered in this report: Part 01: Market Overview Part 02: Market Size, by regions Part 03: Market Revenue, by countries Part 04: Market Competition, by key players Part 05: Company Profiles

To view more details on this report, click on the link https://www.rootsanalysis.com/reports/plasma-fractionation-market.html

About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

13
 
 

The average liter of bottled water has nearly a quarter million invisible pieces of ever so tiny nanoplastics, detected and categorized for the first time by a microscope using dual lasers.

Scientists long figured there were lots of these microscopic plastic pieces, but until researchers at Columbia and Rutgers universities did their calculations they never knew how many or what kind. Looking at five samples each of three common bottled water brands, researchers found particle levels ranged from 110,000 to 400,000 per liter, averaging at around 240,000 according to a study in Monday’s Proceedings of the National Academy of Sciences.

These are particles that are less than a micron in size. There are 25,400 microns — also called micrometers because it is a millionth of a meter — in an inch. A human hair is about 83 microns wide.

Previous studies have looked at slightly bigger microplastics that range from the visible 5 millimeters, less than a quarter of an inch, to one micron. About 10 to 100 times more nanoplastics than microplastics were discovered in bottled water, the study found.

. . .

14
 
 

Dec 7 (Reuters) - The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

The policy creates a roadmap for the government's so-called march-in rights, which have never been used before. They would allow the government to grant additional licenses to third parties for products developed using federal funds if the original patent holder does not make them available to the public on reasonable terms.

White House advisers said on a press call that cost to consumers is a factor government agencies may consider when thinking of using march-in rights.

"We'll make it clear that when drug companies won't sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less," White House adviser Lael Brainard said on the call.

. . .

15
 
 

cross-posted from: https://infosec.pub/post/2473461

cross-posted from: https://infosec.pub/post/2473459

Americans' Exposure to Harmful Industrial Chemicals Must Be Addressed https://www.theepochtimes.com/opinion/americans-exposure-to-harmful-industrial-chemicals-must-be-addressed-5377012 By 2045, the trends suggest, the median man will have a sperm count of zero: half of all men will produce no sperm at all, and the other half will produce so few that they might as well produce none. This is often referred to as a “spermageddon” scenario.

16
17
18
19
20
21
22